Drug profile

The FDA adverse-event record for Bordetella Parainfluenza Vaccine

37 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bordetella Parainfluenza Vaccine. See the species affected, top reactions, and outcomes below.

37
adverse-event reports
8.1%
death-coded share
Dog
most-reported species
12
Emesis - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
37
Total Reports
3
Deaths Reported
8.1%
Death Rate

Active Ingredients

Bordetella Parainfluenza Vaccine

Administration Routes

UnknownNasalOral

Species Affected

Dog 37

Most Affected Breeds

Retriever - Labrador 5
Boxer (German Boxer) 4
Crossbred Canine/dog 4
Dachshund (unspecified) 3
Retriever - Golden 3
Shepherd Dog - Australian 2
Shih Tzu 2
Terrier - Yorkshire 2
Retriever (unspecified) 1
Shepherd Dog - German 1

Most Reported Reactions

Emesis 12
Vomiting 6
Diarrhoea 3
Lack of efficacy (endoparasite) - hookworm 3
Not eating 3
Emesis (multiple) 3
UNPALATABLE 2
Seizure NOS 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Lack of efficacy - NOS 2
Itching 2
Injection site pain 2

Outcome Breakdown

Recovered/Normal
22 (59.5%)
Outcome Unknown
7 (18.9%)
Ongoing
4 (10.8%)
Euthanized
2 (5.4%)
Recovered with Sequela
1 (2.7%)
Died
1 (2.7%)

Bordetella Parainfluenza Vaccine Adverse Event Insights

37 reports name Bordetella Parainfluenza Vaccine; 3 recorded a death outcome (8.1% of reported events, not a population-level mortality rate). Active ingredient: Bordetella Parainfluenza Vaccine. Administration routes: Unknown, Nasal, Oral.

By species: Dog (37 reports). By breed: Retriever - Labrador (5), Boxer (German Boxer) (4), Crossbred Canine/dog (4).

Leading clinical signs: Emesis (12), Vomiting (6), Diarrhoea (3), Lack of efficacy (endoparasite) - hookworm (3). Outcome, 37 coded reports: Recovered/Normal leads at 59.5%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.